AMACR
In 2006, it is estimated that 234,460 men will be diagnosed with prostate cancer, and 27,350 will die from their disease. Prostate cancer is the most common malignancy in men and is the third leading cause of cancer-related death in men (behind lung cancer and colon cancer). In an effort to lower these numbers, researchers are investigating many possible markers for prostate cancer. These markers may one day help identify men at higher risk.
An...
Read moreIn this era of minimally invasive medicine, one of the options for the treatment of prostate cancer is the use of radiation therapy. This... Read more »
My father was diagnosed with prostate cancer in 2002. I still remember going with him to his doctor's appointment where we nervously sat in... Read more »
Radiation therapy is one of the more commonly used methods for the treatment of localized prostate cancer. It involves the use of ionizing... Read more »
A fascinating study out of the National Cancer Institute has significant implications for men at risk for prostate cancer and men with... Read more »
Happy New Year. I would like to start the New Year answering one of ProstateCommons SharePosts. An overweight man with diabetes was... Read more »
Source: National Cancer Institute
Colorectal Cancer Research from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: NCI Fact Sheet Key Points • • • The... Read more »
(Ivanhoe Newswire) -- Body mass and weight gain in middle age may influence a man's risk for prostate cancer, but this risk varies among different... Read more »
Source: Medifocus Guidebook on: Prostate Cancer
The first decision in the management of patients with prostate cancer is how aggressively the cancer is to be treated. Aggressive treatment usually... Read more »
Source: ADAM Encyclopedia
Other TreatmentsAndrogen Suppression GuidelinesMale hormones (called androgens), particularly testosterone and dihydrotestosterone, determine male... Read more »
Mass screening for prostate cancer with a test for prostate-specific antigen has led to mass over-diagnosis and over-treatment, a new study contends. Read more »